Clinical Trials List
2024-09-01 - 2028-06-30
Phase III
Recruiting4
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- 鄧齡喬 Division of Hematology & Oncology
- Chieh-Lin Teng Division of Hematology & Oncology
- PO-WEI LIAO Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- 陳泉翰 Division of Radiology
- HSIN-CHEN LIN Division of Hematology & Oncology
- PO-HSIEN LI Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 傅蓓安 Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- Tsai-Yun Chen Division of Hematology & Oncology
- Ya-Ting Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李思慧 Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- 劉高郎 Division of Hematology & Oncology
- YAO CHI-YUAN Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- 林明恩 Division of Hematology & Oncology
- MEI-FANG CHENG Division of Nuclear Medicine
- SHAN-CHI YU 無
- Wen-Chien Chou Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王幸婷 Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Che-Hung Lin Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
360 participants